
|Articles|January 1, 2004
New medications for rheumatoid arthritis are effective but expensive
Author(s)Elaine Zablocki
First line treatment usualy begins with NSAIDs plus a DMARD, but combination therapy and new biologics hold great promise
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
TrumpRx launches; some experts question its long-term value
4
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
5

























